Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-136654
Filing Date
2025-06-06
Accepted
2025-06-06 11:35:15
Documents
6
Period of Report
2025-06-06

Document Format Files

Seq Description Document Type Size
1 6-K d81295d6k.htm 6-K 8982
2 EX-99.1 d81295dex991.htm EX-99.1 17573
3 EX-99.2 d81295dex992.htm EX-99.2 38689
4 EX-99.3 d81295dex993.htm EX-99.3 17070
5 GRAPHIC g81295g04g01.jpg GRAPHIC 18054
6 GRAPHIC g81295g04g02.jpg GRAPHIC 10931
  Complete submission text file 0001193125-25-136654.txt   123521
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251029490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)